KEVZARA 150 MG / 1.14 ML
SARILUMAB : 150 MG / 1.14 ML · DIN 02460521 · SANOFI-AVENTIS CANADA INC
Health Canada status: CANCELLED POST MARKET
What is KEVZARA?
KEVZARA 150 MG / 1.14 ML contains SARILUMAB : 150 MG / 1.14 ML. It is listed in the Health Canada Drug Product Database under DIN 02460521, held by SANOFI-AVENTIS CANADA INC, supplied as SOLUTION for SUBCUTANEOUS administration. Health Canada currently lists it as cancelled post market, status dated 02-Aug-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02460521 |
|---|---|
| Brand name | KEVZARA |
| Generic / active ingredient | SARILUMAB : 150 MG / 1.14 ML |
| Manufacturer | SANOFI-AVENTIS CANADA INC |
| Strength | 150 MG / 1.14 ML |
| Dosage form | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Schedule | Prescription |
| ATC code | L04AC14 SARILUMAB |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 02-Aug-2022 |
What can be used instead?
Other Canadian products sharing ATC code L04AC14 SARILUMAB. 3 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| KEVZARA | 150 MG / 1.14 ML | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02472961 |
| KEVZARA | 200 MG / 1.14 ML | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02460548 |
| KEVZARA | 200 MG / 1.14 ML | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02472988 |
Who else supplies SARILUMAB worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SARILUMAB appears in 18 registered pack listings across 5 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.